JHS Svendgaard Laboratories Intrinsic Value
JHS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹26.40 | ₹23.76 - ₹29.04 | +150.0% | Book Value/Share: ₹20.12, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹16.05 | ₹14.45 - ₹17.66 | +52.0% | Revenue/Share: ₹10.70, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹9.77 | ₹8.79 - ₹10.75 | -7.5% | EBITDA: ₹8.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹26.40 | ₹21.12 - ₹31.68 | +150.0% | CF Growth: 15.0%, Discount: 15% |
Want to compare with current market value? Check JHS share price latest .
Valuation Comparison Chart
JHS Intrinsic Value Analysis
What is the intrinsic value of JHS?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of JHS Svendgaard Laboratories (JHS) is ₹26.40 (median value). With the current market price of ₹10.56, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹9.77 to ₹26.40, indicating ₹9.77 - ₹26.40.
Is JHS undervalued or overvalued?
Based on our multi-method analysis, JHS Svendgaard Laboratories (JHS) appears to be trading below calculated value by approximately 150.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 13.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.16 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.46x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for JHS Svendgaard Laboratories
Additional stock information and data for JHS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-5 Cr | ₹-15 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-9 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹23 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-9 Cr | ₹-12 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹12 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |